Cargando…
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Protein–protein interactions (PPIs) execute many fundamental cellular functions and have served as prime drug targets over the last two decades. Interfering intracellular PPIs with small molecules has been extremely difficult for larger or flat binding sites, as antibodies cannot cross the cell memb...
Autores principales: | Lee, Andy Chi-Lung, Harris, Janelle Louise, Khanna, Kum Kum, Hong, Ji-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566176/ https://www.ncbi.nlm.nih.gov/pubmed/31091705 http://dx.doi.org/10.3390/ijms20102383 |
Ejemplares similares
-
BRCA1 A-Complex fine tunes repair functions of BRCA1
por: Harris, Janelle L, et al.
Publicado: (2011) -
Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice
por: Tomimatsu, Nozomi, et al.
Publicado: (2014) -
Artificial protein and peptide nanofibers: design, fabrication, characterization, and applications
por: Wei, Gang, et al.
Publicado: (2020) -
Peptidyl-prolyl isomerization for cytokinetic abscission: Fold and cut
por: van der Horst, Armando, et al.
Publicado: (2012) -
Complexities of pharmacogenomic interactions in cancer
por: Khanna, Kum Kum, et al.
Publicado: (2020)